HoxA9 Antibodies

Santa Cruz Biotechnology offers a broad range of HoxA9 monoclonal antibodies for research focused on understanding this critical transcription factor. HoxA9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HoxA9 is a member of the homeobox gene family, which plays a vital role in regulating gene expression during embryonic development and cell differentiation. HoxA9 functions are particularly important in hematopoiesis and have been implicated in various cancers, including leukemia. Research has shown that HoxA9 expression levels can significantly impact cellular development and disease progression. Understanding HoxA9's molecular interactions and regulatory mechanisms provides essential insights into developmental biology and pathological conditions. Investigating HoxA9's role in normal and disease states can reveal potential therapeutic targets. Advanced research techniques using HoxA9 monoclonal antibodies enable precise detection and analysis of protein expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies for HoxA9 support researchers worldwide in advancing our understanding of developmental processes and disease mechanisms.